nVerses Capital’s Abbott ABT Stock Holding History

nVerses Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,187	Closed	-$274K	–	350
2025 Q4	$274K	Buy	+2,187	New	+$279K	0.61%	58

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

nVerses Capital's ABT Position: Q1 2026 in Review

nVerses Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 2,187 shares — an estimated $274K sold.

nVerses Capital first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $274K in Q4 2025. 3,102 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

nVerses Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
nVerses Capital sold 2,187 Abbott shares in Q1 2026, an estimated $274K.
nVerses Capital first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
nVerses Capital's Abbott position peaked at $274K in Q4 2025.
3,102 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.